Table 2.

Laboratory findings at 24 weeks, end of treatment and one month after end of treatment.

	Baseline	24 weeks	P	End of treatment (ETR) 12 months	P	1 month after end of treatment	p
ALT UI/ml (mean ± SD)	169 ± 129	131 ± 61	NS	95 ± 61	NS	79 ± 75	NS
HCV-RNA × 106geq/ml (mean ± SD)	28.3 ± 36.6	9.2 ± 12.4	0.66	1.4 ± 1.6	0.07	39.07 ± 20.22	NS